Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2004-09-03
2010-06-08
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S105000, C546S122000, C546S139000, C546S152000, C546S297000
Reexamination Certificate
active
07732442
ABSTRACT:
The present invention relates to a compound represented by formula (I), a salt thereof, an N-oxide thereof, a solvate thereof or a prodrug thereof, and medical use thereof (the symbols in the formula are as described in the specification).The compound represented by formula (I) has chemokine receptor (especially in CCR4 and/or CCR5) antagonistic activity. Therefore it is useful for prevention and/or treatment of a chemokine receptor-mediated disease such as inflammatory and/or allergic diseases [systemic inflammatory response syndrome (SIRS), anaphylaxis, anaphylactoid reaction, allergic angiitis, transplant rejection reaction, hepatitis, nephritis, nephropathy, pancreatitis, rhinitis, arthritis, inflammatory ocular disease, inflammatory bowel disease, disease in cerebro and/or circulatory system, respiratory disease, dermatosis, autoimmune disease, and the like], infection [viral disease (human immunodeficiency virus infection, acquired immunodeficiency syndrome, SARS, etc.), and the like], and the like.
REFERENCES:
patent: 5403930 (1995-04-01), Agback et al.
patent: 6448290 (2002-09-01), Ohuchida et al.
patent: 2006/0004010 (2006-01-01), Habashita et al.
patent: 93/10094 (1993-05-01), None
patent: 0198273 (2001-12-01), None
patent: 02/30358 (2002-04-01), None
patent: 02076457 (2002-10-01), None
patent: 03018566 (2003-03-01), None
patent: 03018576 (2003-03-01), None
patent: 03051870 (2003-06-01), None
patent: 03059893 (2003-07-01), None
patent: 2004005295 (2004-01-01), None
patent: 2004007472 (2004-01-01), None
patent: 2005/021513 (2005-03-01), None
patent: 2006/002284 (2006-01-01), None
West, Anthony R., Solid State Chemistry and its Applications, Wiley, New York, 1988, pp. 358 and 365.
Wolff, Manfred E. “Burger's Medicinal Chemistry, 5ed, Part I”, John Wiley & Sons, 1995, pp. 975-977.
Banker (Modern Pharmaceutics) Banker, G.S. et al, “Modern Pharmaceutics, 3ed.”, Marcel Dekker, New York, 1996, pp. 451 and 596.
International Serach Report dated Nov. 22, 2004.
Supplemental European Search Report issued in European Patent Application No. 04772925.6-2101/1661889; dated Jul. 6, 2009.
Habashita Hiromu
Komiya Takaki
Ochiai Hiroshi
Shibayama Shiro
Takeda Kazuhiko
McDowell Brian
Ono Pharmaceutical Co. Ltd.
Sughrue & Mion, PLLC
Wilson James O
LandOfFree
Chemokine receptor antagonist and medical use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Chemokine receptor antagonist and medical use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chemokine receptor antagonist and medical use thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4230970